Trade Enforcement Needs to Be a Top Priority for Biden Administration


By Frank Samolis


The United States-Mexico-Canada Agreement has been in force for over a year -- but our North American trading partners refuse to fully implement the deal.


Canada has failed to open its dairy market to U.S. farmers and producers, as promised. And Mexico continues to privilege state-owned energy companies over U.S. energy firms, among other violations.


Unfortunately, Canada and Mexico aren't the only U.S. trading partners shirking their commitments. The United Kingdom, Japan, Brazil, and Indonesia are also guilty of erecting trade barriers that threaten U.S. workers and businesses.


Luckily, U.S. Trade Ambassador Katherine Tai pledged that under her watch, the United States would "impart the values and rules that guide global commerce . . . [and] enforce those terms vigorously."


This support for holding our trading partners accountable is extremely encouraging. Enforcing existing trade deals is one of the best ways to help American firms expand into new markets -- and create more jobs here at home.


International trade remains a pillar of the American economy. In 2019, U.S. companies imported and exported $5.6 trillion worth of goods and services. Forty million jobs depend on these transactions.


Unfortunately, when the federal government doesn't properly enforce trade rules abroad, these businesses and their workers get ripped off -- and that's precisely what's happening right now.


Consider that domestic policies in the United Kingdom and Japan undervalue American-made medicines and erect barriers to U.S. biopharmaceutical exports. Meanwhile, local content laws in Brazil and Indonesia limit broadcasts of Hollywood films. Counterfeiting in Mexico also poses a challenge to American manufacturing firms and producers from a variety of IP-intensive sectors.


Individual governments aren't the only ones blocking free and fair commerce. The World Trade Organization is currently considering a proposal that would invalidate IP protections for Covid-19 technologies.


Several WTO members, including the European Union, have opposed the proposal, which would chill research and development projects for years to come. So, it was particularly surprising when the Biden administration came out in support of the proposal earlier this summer. There's still time for the United States to disavow this position -- and it's in the best interest of American researchers and developers that they do.


Strictly enforcing existing agreements will also make it easier for Ambassador Tai to negotiate stronger treaties in the future, like those with Japan and the United Kingdom.


Prior to tabling U.S.-UK trade negotiations just before the 2020 election, negotiators had yet to finalize much-needed chapters on intellectual property and pharmaceutical regulation. Writing robust IP protections into these chapters will generate a truly modern free trade agreement -- one that ought to serve as a model for 21st-century negotiations going forward.


The previous USTR was also unable to secure protections for U.S. medicines in phase one of the U.S.-Japan Trade Agreement. And he didn't address the country's onerous vehicle testing standards that make automobiles the largest source of our trade deficit with Japan. Ambassador Tai can correct both errors.


It's no mystery why stricter enforcement is popular with both parties. Nearly everyone -- from top politicians to ordinary workers -- recognizes that enforcement benefits American businesses.


They're right -- and Ambassador Tai now has the opportunity to grow the U.S. economy by holding our trading partners accountable. Here's hoping she'll succeed.


Frank Samolis, an attorney, is a partner and co-chair of the International Trade Practice at Squire Patton Boggs. This piece originally ran in the International Business Times.

More Resources


01/25/2025
The Cold Civil War Is Over
The civilizational inflection point in our cold civil war happened sometime between Donald Trump's second inaugural address on Monday and the end of his new presidency's second day on Tuesday. At some indeterminate moment between Monday's soaring midday speech, in which the first nonconsecutive two-term president in over 130 years artfully took a sledgehammer to the entire Obama-Biden era legacy without so much as uttering the men's names, and Tuesday's epochal executive order coming as close as legally possible to banning wokeism throughout the republic, the war ended. And as with the...

more info


01/25/2025
A Test Case for Democrats Charting Their Future
Until hours before California Gov. Gavin Newsom greeted President Donald Trump with a bro-hug on the Los Angeles tarmac Friday, his advisers had spent the week monitoring new White House advance staffers' social media accounts, hoping for clues for where Trump was going to talk about the wildfire damage.

more info


01/25/2025
Ritchie Torres: 'We Should Break That Cycle of Insanity'
The Bronx's moderate congressman on Israel, immigration, Daniel Penny and the possibility of a primary challenge against Gov. Kathy Hochul.

more info


01/25/2025
Corrupt Reporters Give a Taste of How It Worked in 2020
Two former staffers at the far-left Politico confirmed what everyone already knew about Politico: it protects Democrats.

more info


01/25/2025
...On Day One
My first reaction was hopeful: He was wearing a blue tie with red dots that came across as purplish. Purplish, not his usual brazen red. Ah, unity? Trump cares about appearances. He sends messages through appearances. He also didn't use the term "American Carnage" in his Inaugural Address, which was nice. He opened and closed with optimism-a new golden age (and you can be part of it by purchasing Trump coins and crypto, on the website).

more info


01/25/2025
A Common Sense Revolution To Restore America
Thomas Carlyle would have been impressed by Donald Trump. The author of On Heroes, Hero-Worship, and the Heroic in History (1841) thought that history organised itself around great men the way that iron filings form patterns in a magnetic field.

more info


01/25/2025
A Line-by-Line Breakdown of Birthright Citizenship Order
Almost every sentence of the order is wrong, misleading, or flagrantly unconstitutional.

more info


01/25/2025
Birthright Citizenship Is a Pernicious Lie
Beyond the legal arguments about the 14th Amendment is the moral argument: who is America for, and what makes someone an American?

more info


01/25/2025
Sen. Warren Sends Musk Spending Cut Ideas
The Senator sent Musk a letter with 30 ideas for how his DOGE commission could cut $2 trillion in U.S. spending.

more info


01/25/2025
Target Rolls Back DEI: What's Changing and How It Happened
All right, most of y'all already know what I do here. We expose woke companies and we get them changed and today we've got a new company to talk about and that company is Target. Target, as many of you know, has had a major wokeness problem for years now.

more info


01/25/2025
Yes, Reshoring American Industry Is Possible
Americans can make stuff, after all.

more info


01/25/2025
Republicans Must Confirm Trump's Nominees
The American people elected Trump as a wartime president. Moderate Republicans should get on board or get out of the way.

more info


01/25/2025
Rohit Chopra Still Has a Job
The Consumer Financial Protection Bureau head has not been fired. Apparently, it's because the Trump team can't find anyone to replace him.

more info


01/25/2025
Bernie Sanders: Kingmaker
Bernie Sanders isn't the Democrats' presidential heir apparent; he's their coming kingmaker. The Democrats' discredited establishment and glaring need to counter Republicans' rising populist wave argue for it. The Democrats' continuing leftward lurch calls for it. Finally, the Democrats' historical precedent presages it.

more info


01/25/2025
China as It Is
Americans imagine that inside every Chinese person is an American struggling to get out. But China defies Western categories.

more info



Custom Search

More Politics Articles:

Related Articles

Congress: Let's Talk About Trade Enforcement


The Trump administration has set an ambitious trade agenda for the remainder of 2020. In a House Ways and Means Committee hearing earlier this summer, U.S. Trade Representative Robert Lighthizer stressed the president's intent to crack down on foreign countries that discriminate against American business and innovators.

With Biomedical Research, Taxpayers are Getting a Great Deal


Gilead Sciences' novel drug remdesivir has shown immense promise for treating coronavirus. Yet every time a company develops a promising drug, some policymakers call for the government to take control of the compound in question.

Marx on Christianity, Judaism, and Evolution/Race


"If someone calls it socialism," said the Rev. William Barber at an August 2019 conference of the Democratic National Committee, "then we must compel them to acknowledge that the Bible must then promote socialism, because Jesus offered free health care to everyone, and he never charged a leper a co-pay."

Abusing March-in Rights Would Jeopardize COVID-19 Research


Thirty-one state attorneys general recently urged the Trump administration to disregard the intellectual property protections on remdesivir -- the only FDA-approved treatment for COVID-19 -- and then license its patents to multiple drug manufacturers.

Judge Amy Coney Barrett and the Purdue Sexual Assault Case


Will some senators on the Senate Judiciary Committee vilify Judge Amy Coney Barrett, President Trump's Supreme Court nominee? Attacks on her religion, her large family, or claims that she will block the advance of women may make good fodder for Facebook, but senators who pursue those tacks are likely to reap public disapproval from their own constituents. What is more likely is that liberal senators will take a page from liberal/progressive organizations like Public Justice and portray Barrett as soft on and complicit with campus sexual abusers. How?

President Trump's Executive Order Will Put an End to Pharmaceutical Breakthroughs


Every day, scientists get closer to a COVID-19 vaccine. A handful of biopharmaceutical firms hope to make one available by year's end.

The Mayflower Mystique: Remembering the Pilgrims


Few can name which groups the Godspeed and the Arabella brought to America. They were the Jamestown colonists in 1607 and the Puritans to Massachusetts Bay Colony in 1630, respectively. But the Mayflower, which brought the Pilgrims to Plymouth in 1620, has sailed into history and ranks with the Titanic, the Lusitania, the Bismarck, and the Queen Mary as the world’s most famous ships. What accounts for the Mayflower’s mystique?

COVID's Second Wave Underscores the Threats Facing Disabled Americans


The second wave of COVID-19 has arrived with a vengeance.

Triumph of the Vaccine—No Shape-Shifting Enemy


Here’s a thought experiment. What if our experience with COVID-19 turns out to be a warm-up for responding to a worse plague in the future? COVID-19 is devastating for a significant number of older people but relatively innocuous for the young. I am thankful that this is not like the Justinian plague, nor the Athenian one, nor like smallpox. What if—God forbid—we find ourselves hosting a plague like one of these? Something as deadly as Ebola but as infectious as SARS-CoV-2?

Who is Perfect? Biden, Trump, McConnell, Pelosi?


Democrats have proven once again that they can find fault in President Donald Trump. Faults and flaws were found in him before the election. Many years before politics there were never any rave reviews about him being perfect.

The 340B Prescription-Drug Swindle Has Gone on Long Enough


In a recent hearing, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services.

Vaccination is the Ticket to Getting the U.S. Back On Track


The end of the pandemic in the U.S. is in sight. The Covid-19 vaccines currently available in the United States have proven to be outstandingly effective at protecting recipients from coronavirus and they are also safe.

Private Deborah Sampson, 'The Female Soldier'


There are those who would say that Private Deborah Sampson deserved the Medal of Honor, but she didn’t sign up for that; she joined the Army to fight for her country and wound up making history. Private Sampson was America’s first woman combat soldier. She served, disguised as a man by the name of Robert Shurtleff, under the command of General George Washington in the Continental Army during the American Revolution.

The End of Covid-19 Could Start in the Hair Salon


President Biden has floated an ambitious goal -- vaccinate enough Americans to achieve some sense of normalcy by July 4.

President Biden Is Right to Redefine Infrastructure


President Biden is in ongoing talks to discuss his multi-trillion-dollar infrastructure plan. Ever since its release, critics have claimed that many aspects of the plan have nothing to do with infrastructure.

America Needs Strong Patent Laws to Keep Inventing


In May, the Biden administration announced its support for a proposal at the World Trade Organization to suspend international intellectual property protections on Covid-19 vaccines.